| 51. |
- Khaleva, E, et al.
(författare)
-
Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)
- 2023
-
Ingår i: The European respiratory journal. - : European Respiratory Society (ERS). - 1399-3003 .- 0903-1936. ; 61:4
-
Tidskriftsartikel (refereegranskat)abstract
- Effectiveness studies with biological therapies for asthma lack standardised outcome measures. The COMSA (Core Outcome Measures sets for paediatric and adult Severe Asthma) working group sought to develop Core Outcome Measures (COM) sets to facilitate better synthesis of data and appraisal of biologics in paediatric and adult asthma clinical studies.MethodsCOMSA utilised a multi-stakeholder consensus process among patients with severe asthma, adult, and paediatric clinicians, pharmaceutical representatives and health regulators from across Europe. Evidence included a systematic review of development, validity, and reliability of selected outcome measures plus a narrative review and a pan-European survey to better understand patients’ and carers’ views about outcome measures. It was discussed using a modified GRADE Evidence to Decision framework. Anonymous voting was conducted using predefined consensus criteria.ResultsBoth adult and paediatric COM sets include forced expiratory volume in 1 s (FEV1) as z scores, annual frequency of severe exacerbations and maintenance oral corticosteroid use. Additionally, the paediatric COM set includes the Paediatric Asthma Quality of Life Questionnaire, and Asthma Control Test (ACT) or Childhood-ACT while the adult COM includes the Severe Asthma Questionnaire and the Asthma Control Questionnaire-6 (symptoms and rescue medication use reported separately).ConclusionsThis patient-centred collaboration has produced two COM sets for paediatric and adult severe asthma. It is expected that they will inform the methodology of future clinical trials, enhance comparability of efficacy and effectiveness of biological therapies, and help assess their socioeconomic value. COMSA will inform definitions of non-response and response to biological therapy for severe asthma.
|
|
| 52. |
- Magdalinou, N. K., et al.
(författare)
-
Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics
- 2017
-
Ingår i: Parkinsonism & Related Disorders. - : Elsevier BV. - 1353-8020 .- 1873-5126. ; 37, s. 65-71
-
Tidskriftsartikel (refereegranskat)abstract
- Introduction: Neurodegenerative parkinsonian syndromes have significant clinical and pathological overlap, making early diagnosis difficult. Cerebrospinal fluid (CSF) biomarkers may aid the differentiation of these disorders, but other than a-synuclein and neurofilament light chain protein, which have limited diagnostic power, specific protein biomarkers remain elusive. Objectives: To study disease mechanisms and identify possible CSF diagnostic biomarkers through discovery proteomics, which discriminate parkinsonian syndromes from healthy controls. Methods: CSF was collected consecutively from 134 participants; Parkinson's disease (n = 26), atypical parkinsonian syndromes (n = 78, including progressive supranuclear palsy (n = 36), multiple system atrophy (n = 28), corticobasal syndrome (n = 14)), and elderly healthy controls (n = 30). Participants were divided into a discovery and a validation set for analysis. The samples were subjected to tryptic digestion, followed by liquid chromatography-mass spectrometry analysis for identification and relative quantification by isobaric labelling. Candidate protein biomarkers were identified based on the relative abundances of the identified tryptic peptides. Their predictive performance was evaluated by analysis of the validation set. Results: 79 tryptic peptides, derived from 26 proteins were found to differ significantly between atypical parkinsonism patients and controls. They included acute phase/inflammatory markers and neuronal/synaptic markers, which were respectively increased or decreased in atypical parkinsonism, while their levels in PD subjects were intermediate between controls and atypical parkinsonism. Conclusion: Using an unbiased proteomic approach, proteins were identified that were able to differentiate atypical parkinsonian syndrome patients from healthy controls. Our study indicates that markers that may reflect neuronal function and/or plasticity, such as the amyloid precursor protein, and inflammatory markers may hold future promise as candidate biomarkers in parkinsonism. (C) 2017 Published by Elsevier Ltd.
|
|
| 53. |
|
|
| 54. |
|
|
| 55. |
|
|
| 56. |
|
|
| 57. |
|
|
| 58. |
- Rusanova, Daniela, et al.
(författare)
-
Copper(I) O,O '-dialkyldithiophosphate clusters : EXAFS, NMR and X-ray diffraction studies
- 2007
-
Ingår i: Journal of coordination chemistry (Print). - : Informa UK Limited. - 0095-8972 .- 1029-0389. ; 60:5, s. 517-525
-
Tidskriftsartikel (refereegranskat)abstract
- Copper K- edge EXAFS data for six polycrystalline cubic cluster compounds, {Cu-8[ S2P(OR)(2)](6)(mu(8)- S)} with R= Et, Pr-n, Pr-i, Bu-n, Bu-i and Am-i, show that the architecture of their Cu-8(S2P)(2)S cores is fairly rigid and independent of both length and branching of the alkyl chain, and that the structure of the cluster is maintained in acetone solution. Solid- state P-31 CP-MAS and static Cu-65 NMR data for {Cu-8[S2P(O-n Pr)(2)] 6(mu(8)- S)} and {Cu-8[S2P(OEt)(2)](6) mu(8)- S)} show similarities in the icosahedral O,O'- dialkyldithiophosphate shells and in the `cubic' copper cores in these cluster compounds. The crystal structure of {Cu-8[S2P(O-n Pr)(2)](6) (mu(8)- S)} was resolved using single- crystal X- ray diffraction.
|
|
| 59. |
|
|
| 60. |
- Russell, C. L., et al.
(författare)
-
Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study
- 2017
-
Ingår i: Rapid Communications in Mass Spectrometry. - : Wiley. - 0951-4198. ; 31:2, s. 153-159
-
Tidskriftsartikel (refereegranskat)abstract
- RationaleIdeal biomarkers are present in readily accessible samples including plasma and cerebrospinal fluid (CSF), and are directly derived from diseased tissue, therefore likely to be of relatively low abundance. Traditional unbiased proteomic approaches for biomarker discovery have struggled to detect low-abundance markers due to the high dynamic range of proteins, the predominance of hyper-abundant proteins, and the use of data-dependent acquisition mass spectrometry (MS). To overcome these limitations and improve biomarker discovery in peripheral fluids, we have developed TMTcalibrator; a novel MS workflow combining isobarically labelled diseased tissue digests in parallel with an appropriate set of labelled body fluids to increase the chance of identifying low-abundance, tissue-derived biomarkers. MethodsA disease relevant cell line was labelled with TMT (R) in a range of concentrations generating a multi-point calibration curve. Peripheral biofluid samples were labelled with the remaining tags and quantitative analysis was performed using an Orbitrap Fusion Tribrid mass spectrometer with a Top10 CID-HCD MS3 synchronous precursor selection (SPS) method. SPS allowed direct analysis of non-depleted, unfractionated CSF samples with complete profiling of six individual samples requiring only 15hours of MS time, equivalent to 1.5h per sample. ResultsUsing the TMTcalibrator workflow allowed the identification of several markers of microglia activation that are differentially quantified in the CSF of patients with Alzheimer's disease (AD). We report peptides from 41 proteins that have not previously been detected in the CSF, that appear to be regulated by at least 60% in AD. ConclusionsThis study has demonstrated the benefits of the new TMTcalibrator workflow and the results suggest this is a suitable and efficient method of detecting low-abundance peptides within biological fluids. The use of TMTcalibrator in further biomarker discovery studies should be considered to overcome some of the limitations commonly associated with more conventional approaches.
|
|
| 61. |
|
|
| 62. |
- Smith, A., et al.
(författare)
-
Application of penetrators within the solar system
- 2010
-
Ingår i: <em>Advances in Geosciences 19.</em> Planetary Science (PS). - Singapore : World Scientific. ; , s. 307-320
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)
|
|
| 63. |
|
|
| 64. |
|
|
| 65. |
|
|
